Aliaxin® GP Global Performance

Where can I buy this product?

Aliaxin® GP (Global Performance) is available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license. First-time buyers can register an online account by providing required professional information, including medical license verification and a valid shipping address. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support. We are committed to ensuring all products are sourced and sold exclusively to qualified professionals.

Product Information

What is Aliaxin® GP (Global Performance)?

Aliaxin® GP is a sterile, monophasic hyaluronic acid (HA) dermal filler, part of the Aliaxin® collection manufactured by IBSA Farmaceutici Italia. The “GP” stands for Global Performance, indicating its versatility for treating common facial aging concerns. It is formulated using ultrapure HA with specific molecular weights to achieve balanced viscoelastic properties suitable for correcting moderate to pronounced wrinkles and folds.

Aliaxin® GP is designed for seamless integration into the dermis, providing effective correction while maintaining natural facial expression. It typically contains 25mg/mL of cross-linked HA and includes 0.3% lidocaine hydrochloride for improved patient comfort during injection. Its rheological profile makes it well-suited for areas like nasolabial folds and marionette lines.

Storage: Aliaxin® GP should be stored between 2°C and 28°C (36°F and 82°F) – (Note: Verify exact range from product insert if possible, 2-25°C is also common). Do not freeze. Protect from light.

Authenticity: Health Supplies Plus guarantees that all Aliaxin® products are authentic, sourced through appropriate channels, and handled according to manufacturer specifications.

Note: For professional use only.

How does Aliaxin® GP (Global Performance) work?

Aliaxin® GP works by physically restoring volume to the dermal tissue where wrinkles and folds have formed due to aging, volume loss, and repetitive facial movements. When injected into the mid-to-deep dermis, the cross-linked HA gel lifts and supports the tissue, smoothing the appearance of lines like nasolabial folds and marionette lines.

IBSA’s formulation process aims to create a gel with optimal cohesivity and elasticity for this ‘global performance’ role, allowing it to integrate well with surrounding tissue while providing durable correction. The hydrophilic nature of HA also helps maintain hydration in the treated area.

Results are typically visible immediately after treatment, with refinement as any initial swelling subsides. The duration of effect for Aliaxin® GP generally lasts from 6 to 12 months, varying based on individual patient factors, injection site, and volume used. The inclusion of lidocaine enhances the treatment experience by minimizing procedural discomfort.

Indications for Use

Aliaxin® GP is indicated for adults seeking correction of moderate to pronounced facial wrinkles and folds. Specific applications include:

• Treatment of nasolabial folds.
• Correction of marionette lines.
• Addressing other moderate-to-deep facial creases or depressions.
• General facial rejuvenation requiring volume restoration in the mid-to-deep dermis.

Appropriate patient selection and injection technique are essential, based on thorough assessment and consideration of contraindications outlined in the product’s Instructions for Use (IFU).

Primary Benefits

• Versatile filler suitable for common facial wrinkles and folds (e.g., nasolabial, marionette).
• Formulated for natural-looking correction and smooth tissue integration.
• Provides immediate volumizing and smoothing effects.
• Contains lidocaine for enhanced patient comfort.
• Utilizes ultrapure HA aiming for high biocompatibility.

Side Effects and Safety Information

Practitioners must consult the complete Instructions for Use (IFU) provided with the product for comprehensive information on indications, contraindications, warnings, precautions, and potential adverse events. It is essential to discuss all potential risks and side effects with patients prior to treatment.

Common side effects are typically mild, temporary, and related to the injection site, including:

• Swelling
• Bruising
• Redness
• Tenderness or Pain
• Itching
• Firmness or Lumps/Bumps at the injection site (should resolve)

Severe Adverse Events:
As with any dermal filler injection, there are risks of more serious complications. Practitioners must possess thorough anatomical knowledge, use appropriate injection techniques, and be prepared to manage complications. Potential severe adverse events include:

• Vascular Occlusion (VO): Accidental injection into a blood vessel can obstruct blood flow, potentially leading to tissue necrosis (tissue death), scarring, or (in rare cases) blindness or stroke. Careful technique and anatomical awareness are crucial.
• Severe allergic reactions (anaphylaxis)
• Inflammation, infection, or abscess formation
• Granuloma or persistent nodule formation
• Migration of filler
• Prolonged pain or numbness
• Herpetic eruptions (cold sores) in susceptible individuals